The Natural Course of Peptic Ulcer Disease and its Predictors

References

• Freston J W. Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin North Am 1990; 19: 121–41
   PubMed Web of Science ®Google Scholar
• Penston J G, Wormsley K G. Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther 1992; 6: 3–29
   PubMed Web of Science ®Google Scholar
• Gustavsson S, Holmberg L, Nyrén O, et al. Risk of serious complications in patients with duodenal or prepyloric ulcers. Gastroenterology 1990; 98: A54
   Google Scholar
• Berstad K, Berstad A. Helicobacter pylori infection in peptic ulcer disease [review]. Scand J Gastroenterol 1993; 28: 561–7
   PubMed Web of Science ®Google Scholar
• Misiewicz J J. Helicobacter pylori: past, present, and future. Scand J Gastroenterol 1992; 27(Suppl 194)25–9
   PubMedGoogle Scholar
• Elashoff J D, Van Deventer G, Reedy T J, et al. Long-term follow-up of duodenal ulcer patients. J Clin Gastroenterol 1983; 5: 509–15
   PubMed Web of Science ®Google Scholar
• Greibe J, Bugge P, Gjørup T, et al. Long-term prognosis of duodenal ulcer: follow-up study and survey of doctors' estimates. Br Med J 1977; 2: 1572–4
   PubMed Web of Science ®Google Scholar
• Pulvertaft C N. Comments on the incidence and natural history of gastric and duodenal ulcer. Postgrad Med J 1968; 44: 597–602
   PubMed Web of Science ®Google Scholar
• Viskum K. A review of 295 patients with duodenal ulcer. A follow-up study 12–14 years after admission. Acta Med Scand 1967; 182: 651–62
   PubMedGoogle Scholar
• Krag E. Long-term prognosis in medically treated peptic ulcer. A clinical, radiographical and statistical follow-up study. Acta Med Scand 1966; 180: 657–68
   PubMedGoogle Scholar
• Krause U. Long-term results of medical and surgical treatment of peptic ulcer. A follow-up investigation of patients initially treated conservatively between 1925–34. Acta Chir Scand 1963; 125(Suppl 310)5–11
   Google Scholar
• Malmros H, Hiertonn T. A post-investigation of 687 medically treated cases of peptic ulcer. Acta Med Scand 1949; 133: 229–52
   PubMedGoogle Scholar
• Martin L, Lewis N. Peptic ulcer cases reviewed after ten years. Effect of medical treatment and indications for gastrectomy. Lancet 1949; 1115–20
   PubMedGoogle Scholar
• Flood C A. Recurrence in duodenal ulcer under medical management. Gastroenterology 1948; 10: 184–99
   PubMedGoogle Scholar
• Qvigstad I, Römcke O. Post-investigation of medically treated gastric and duodenal ulcers. II. Acta Med Scand 1946; 126: 34–9
   Google Scholar
• Karup N B. On the results of the medical treatment of peptic ulcer. Acta Med Scand 1946; 123: 181–207
   PubMedGoogle Scholar
• Pounder R E, Festen H, Korman M. The long-term management of duodenal ulceration using H2-antagonist: symptomatic self-care compared with maintenance treatment. Aliment Pharmacol Ther 1992; 6: 315–25
   PubMed Web of Science ®Google Scholar
• Walan A, Bianchi-Porro G, Hentschel E. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987; 22: 397–405
   PubMed Web of Science ®Google Scholar
• Bardhan K D. Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Aliment Pharmacol Ther 1988; 2: 395–405
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Hameeteman W, Mulder C JJ, et al. Five-year cimetidine maintenance trial for peptic ulcer disease. Scand J Gastroenterol 1990; 25: 974–80
   PubMed Web of Science ®Google Scholar
• Penston J G, Wormsley K G. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther 1992; 6: 629–45
   PubMed Web of Science ®Google Scholar
• Penston J G, Wormsley K G. Long-term maintenance treatment of gastric ulcers with ranitidine. Aliment Pharmacol Ther 1990; 4: 339–55
   PubMedGoogle Scholar
• Kristensen P, Johannessen T, Petersen H. Prescription habits and consumption of acid inhibitory drugs. Scand J Gastroenterol 1992; 27: 39
   PubMedGoogle Scholar
• Waldum H L, Petersen H. Histamin-2-reseptorblokkernes plass innen gastroenterologien. Tidsskr Nor Laegeforen 1983; 103: 980–3
   PubMedGoogle Scholar
• Petersen H. Over the counter sales of histamine-2 receptor antagonists. Scand J Gastroenterol 1988; 23(Suppl 155)20–2
   Google Scholar
• Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993; 28(Suppl 196)34–7
   Google Scholar
• Leape L L, Welch C E. Late prognosis of patients with upper gastrointestinal hemorrhage. Am J Surg 1964; 107: 297–305
   PubMed Web of Science ®Google Scholar
• Serebro H A, Mendeloff A I. Late results of medical and surgical treatment of bleeding peptic ulcer. Lancet 1966; 505–8
   PubMedGoogle Scholar
• Sontag S, Graham D Y, Belsito A, et al. Cimetidine, cigarette smoking and recurrence of duodenal ulcer. N Engl J Med 1984; 311: 689–93
   PubMed Web of Science ®Google Scholar
• Lee F I, Hardmann M, Jaderberg M E. Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers. Gut 1991; 32: 151–3
   PubMedGoogle Scholar
• Battaglia G, Di Mario F, Piccoli A, et al. Clinical markers of slow healing and relapsing gastric ulcer. Gut 1987; 28: 210–5
   PubMed Web of Science ®Google Scholar
• Van Deventer G M, Elashoff J, Reedy T, et al. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989; 320: 1113–9
   PubMed Web of Science ®Google Scholar
• Zuckerman G. Duodenal ulcer. Who should have long-term maintenance therapy?. Postgrad Med 1987; 82: 52–60
   PubMed Web of Science ®Google Scholar
• Zell S, Carmichael J M, Reddy A N. Rational approach to long-term use of H2-antagonists. Am J Med 1987; 82: 797–802
   Google Scholar